Related Experiment Video
Updated: Jun 13, 2026

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains
Ahmad Jowaed1, Ina Schmitt, Oliver Kaut
1Department of Neurology, Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, D-53105 Bonn, Germany.
Abstract:
Alpha-synuclein (SNCA) is a major risk gene for Parkinson's disease (PD), and increased SNCA gene dosage results in a parkinsonian syndrome in affected families. We found that methylation of human SNCA intron 1 decreased gene expression, while inhibition of DNA methylation activated SNCA expression. Methylation of SNCA intron 1 was reduced in DNA from sporadic PD patients' substantia nigra, putamen, and cortex, pointing toward a yet unappreciated epigenetic regulation of SNCA expression in PD.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll
